CADASIL in central Italy: a retrospective clinical and genetic study in 229 patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Joutel A, Corpechot C, Ducros A et al (1996) NOTCH3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383(6602):707–710
Desmond DW, Moroney JT, Lynch T et al (1999) The natural history of CADASIL: a pooled analysis of previously published cases. Stroke 30(6):1230–1233
Mykkänen K, Junna M, Amberla K et al (2009) Different clinical phenotypes in monozygotic CADASIL twins with a novel NOTCH3 mutation. Stroke 40(6):2215–2218
Arboleda-Velasquez JF, Lopera F, Lopez E et al (2002) C455R NOTCH3 mutation in a Colombian CADASIL kindred with early onset of stroke. Neurology 59(2):277–279
Opherk C, Peters N, Herzog J et al (2004) Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain 127(Pt 11):2533–2539
Bianchi S, Rufa A, Ragno M et al (2010) High frequency of exon 10 mutations in the NOTCH3 gene in Italian CADASIL families: phenotypic peculiarities. J Neurol 257(6):1039–1042
Joutel A, Vahedi K, Corpechot C et al (1997) Strong clustering and stereotyped nature of NOTCH3 mutations in CADASIL patients. Lancet 350(9090):1511–1515
Peters N, Opherk C, Bergmann T et al (2005) Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol 62(7):1091–1094
Dotti MT, Federico A, Mazzei R et al (2005) The spectrum of NOTCH3 mutations in 28 Italian CADASIL families. J Neurol Neurosurg Psychiatry 76(5):736–738
Testi S, Malerba G, Ferrarini M et al (2012) Mutational and haplotype map of NOTCH3 in a cohort of Italian patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). J Neurol Sci 319(1–2):37–41
Razvi SS, Davidson R, Bone I et al (2005) The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 76(5):739–741
Moreton FC, Razvi SS, Davidson R et al (2014) Changing clinical patterns and increasing prevalence in CADASIL. Acta Neurol Scand 130(3):197–203
Narayan SK, Gorman G, Kalaria RN et al (2012) The minimum prevalence of CADASIL in northeast England. Neurology 78(13):1025–1027
Chabriat H, Vahedi K, Iba-Zizen MT et al (1995) Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 346(8980):934–939
Dichgans M, Mayer M, Uttner I et al (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44(5):731–739
Kalimo H, Ruchoux MM, Viitanen M et al (2002) CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol 12(3):371–384
Adib-Samii P, Brice G, Martin RJ et al (2010) Clinical spectrum of CADASIL and the effect of cardiovascular risk factors on phenotype: study in 200 consecutively recruited individuals. Stroke 41(4):630–634
Pescini F, Nannucci S, Bertaccini B et al (2012) The Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for NOTCH3 gene analysis. Stroke 43(11):2871–2876
Wang Z, Yuan Y, Zhang W et al (2011) NOTCH3 mutations and clinical features in 33 mainland Chinese families with CADASIL. J Neurol Neurosurg Psychiatry 82(5):534–539
WHO Monica Project Investigators (1988) The World Health Organization MONICA Project (Monitoring trends and determinants in cardiovascular disease). J Clin Epidemiol 41:105–114
International Headache Society Classification Subcommittee (2004) International classification of headache disorders, 2nd edition. Cephalalgia 24(suppl 1):1–160
Blume WT, Lüders HO, Mizrahi E et al (2001) Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 42(9):1212–1218
Whitworth JA, World Health Organization, International Society of Hypertension Writing Group (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21(11):1983–1992
(1987) Lipoproteins and atherosclerosis: current views, future trends. 17–18 October, 1986, Helsinki, Finland. Eur Heart J, 8 Suppl E:1–111. [No authors listed]
Expert Committee on the Diagnosis and Classification of (1997) Diabetes mellitus: report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
Escary JL, Cécillon M, Maciazek J et al (2000) Evaluation of DHPLC analysis in mutatational scanning of NOTCH3, a gene with a high G-C content. Hum Mutat 16(6):518–526
Bianchi S, Dotti MT, De Stefano N et al (2007) Novel human pathological mutations. Gene symbol: NOTCH3. Disease: CADASIL, exon 2 mutation. Hum Genet 122(5):558–559
Rufa A, Guideri F, Acampa M et al (2007) Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Stroke 38(2):276–280
Bianchi S, Dotti MT, Gallus GN et al (2013) First deep intronic mutation in the NOTCH3 gene in a family with late-onset CADASIL. Neurobiol Aging 34(9):2234
Dotti MT, De Stefano N, Bianchi S et al (2004) A novel NOTCH3 frameshift deletion and mitochondrial abnormalities in a patient with CADASIL. Arch Neurol 61(6):942–945
Grigg R, Lea R, Sullivan AA et al (2000) Identification of a novel mutation C144F in the NOTCH3 gene in an Australian CADASIL pedigree. Hum Mutat 16(5):449–450
Joutel A, Corpechot C, Ducros A et al (1996) NOTCH3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383(6602):707–710
Dichgans M, Filippi M, Brüning R et al (1999) Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology 52(7):1361–1367
Dichgans M, Ludwig H, Müller-Höcker J et al (2000) Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of NOTCH3 EGF-like repeat domains. Eur J Hum Genet 8(4):280–285
Lesnik Oberstein SAJ, Ferrari MD, Bakker E et al (1999) Diagnostic NOTCH3 sequence analysis in CADASIL: three new mutations in Dutch patients. Neurology 52(9):1913–1915
Mizuno T (2012) Diagnosis, pathomechanism and treatment of CADASIL. Rinsho Shinkeigaku 52(5):303–313
Oliveri RL, Muglia M, De Stefano N, Mazzei R et al (2001) A novel mutation in the NOTCH3 gene in an Italian family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: genetic and magnetic resonance spectroscopic findings. Arch Neurol 58(9):1418–1422
Lesnik Oberstein SAJ, Razvi SSM, Davidson I, Bone I, Muir KW (2003) Diagnostic strategies in CADASIL. Neurology 60:2019–2020
Bianchi S, Scali O, Dotti MT et al (2005) Gene symbol: NOTCH3. Disease: CADASIL. Hum Genet 118(3–4):534–535
Lesnik Oberstein SAJ, van den Boom R, van Buchem MA et al (2001) Cerebral microbleeds in CADASIL. Neurology 57:1066–1070
Pescini F, Bianchi S, Salvadori E et al (2008) A pathogenic mutation on exon 21 of the NOTCH3 gene causing CADASIL in an octogenarian paucisymptomatic patient. J Neurol Sci 267(1–2):170–173
Valenti R, Bianchi S, Pescini F et al (2011) First report of a pathogenic mutation on exon 24 of the NOTCH3 gene in a CADASIL family. J Neurol 258(9):1632–1636
Kalimo H, Miao Q, Tikka S et al (2008) CADASIL: the most common hereditary subcortical vascular dementia. Future Neurol 3:683–704
Singhal S, Bevan S, Barrick T et al (2004) The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 127(Pt 9):2031–2038
Kim Y, Choi EJ, Choi CG et al (2006) Characteristics of CADASIL in Korea: a novel cysteine-sparing NOTCH3 mutation. Neurology 66(10):1511–1516